Pomerantz JL - Search Results

1

Efficient Immune Cell Genome Engineering with Enhanced CRISPR Editing Tools.

Chan W, Gottschalk RA, Yao Y, Pomerantz JL, Germain RN. Chan W, et al. Among authors: pomerantz jl. Immunohorizons. 2021 Feb 23;5(2):117-132. doi: 10.4049/immunohorizons.2000082. Immunohorizons. 2021. PMID: 33622708 Free article.

2

A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.

Chan W, Schaffer TB, Pomerantz JL. Chan W, et al. Among authors: pomerantz jl. Mol Cell Biol. 2013 Jan;33(2):429-43. doi: 10.1128/MCB.00850-12. Epub 2012 Nov 12. Mol Cell Biol. 2013. PMID: 23149938 Free PMC article.

3

Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181.

Pedersen SM, Chan W, Jattani RP, Mackie dS, Pomerantz JL. Pedersen SM, et al. Among authors: pomerantz jl. Mol Cell Biol. 2015 Dec 28;36(5):794-808. doi: 10.1128/MCB.00876-15. Mol Cell Biol. 2015. PMID: 26711259 Free PMC article.

4

Correction for Pedersen et al., Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181.

Pedersen SM, Chan W, Jattani RP, Mackie dS, Pomerantz JL. Pedersen SM, et al. Among authors: pomerantz jl. Mol Cell Biol. 2016 Mar 31;36(8):1322. doi: 10.1128/MCB.00106-16. Print 2016 Apr. Mol Cell Biol. 2016. PMID: 27034408 Free PMC article. No abstract available.

5

Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.

Yang YK, Yang C, Chan W, Wang Z, Deibel KE, Pomerantz JL. Yang YK, et al. Among authors: pomerantz jl. J Biol Chem. 2016 Dec 9;291(50):25921-25936. doi: 10.1074/jbc.M116.754028. Epub 2016 Oct 24. J Biol Chem. 2016. PMID: 27777308 Free PMC article.

6

NK Cell Maturation and Cytotoxicity Are Controlled by the Intramembrane Aspartyl Protease SPPL3.

Hamblet CE, Makowski SL, Tritapoe JM, Pomerantz JL. Hamblet CE, et al. Among authors: pomerantz jl. J Immunol. 2016 Mar 15;196(6):2614-26. doi: 10.4049/jimmunol.1501970. Epub 2016 Feb 5. J Immunol. 2016. PMID: 26851218 Free PMC article.

7

Transcriptional target-based expression cloning of immunoregulatory molecules.

Lamason RL, Lew SM, Pomerantz JL. Lamason RL, et al. Among authors: pomerantz jl. Immunol Res. 2010 Jul;47(1-3):172-8. doi: 10.1007/s12026-009-8148-z. Immunol Res. 2010. PMID: 20069388 Free PMC article. Review.

8

HOIP for targeting diffuse large B-cell lymphoma.

Pomerantz JL. Pomerantz JL. Blood. 2020 Aug 6;136(6):646-647. doi: 10.1182/blood.2020006242. Blood. 2020. PMID: 32761216 Free article. No abstract available.

9

CARD11 signaling in regulatory T cell development and function.

Carter NM, Pomerantz JL. Carter NM, et al. Among authors: pomerantz jl. Adv Biol Regul. 2022 May;84:100890. doi: 10.1016/j.jbior.2022.100890. Epub 2022 Feb 26. Adv Biol Regul. 2022. PMID: 35255409 Free PMC article. Review.

10

Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation.

Yang HC, Shen L, Siliciano RF, Pomerantz JL. Yang HC, et al. Among authors: pomerantz jl. Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6321-6. doi: 10.1073/pnas.0809536106. Epub 2009 Mar 31. Proc Natl Acad Sci U S A. 2009. PMID: 19336585 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page